Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Axalta Q2 Adj. EPS Outlook: $0.50 Vs. $0.47 Estimate, Adj. EBITDA $275M

Author: Benzinga Newsdesk | May 01, 2024 06:08am

c

Second Quarter And Full Year 2024 Outlook

(in millions, except %'s and per share data) Projection
Item Q2 2024 FY 2024
Net Sales YoY% 3% - 5% +LSD
Adjusted EBITDA ~$275 $1,050 - $1,080
Adjusted Diluted EPS ~$0.50 $1.90 - $2.00
Free Cash Flow $425 - $475
D&A (step-up D&A) ~$280 ($50)
Tax Rate, As Adjusted ~25%
Diluted Shares Outstanding ~222
Interest Expense ~$210
Capex ~$165

Posted In: AXTA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist